myAMDteam

Yes, there is good news! In 2023, the FDA approved two new treatments specifically for advanced dry AMD and geographic atrophy. These are injectable medications called Syfovre (pegcetacoplan) and Izervay (avacincaptad pegol). Both medications work by controlling inflammation and can help slow the progression of the disease Show Full Answer

Yes, there is good news! In 2023, the FDA approved two new treatments specifically for advanced dry AMD and geographic atrophy. These are injectable medications called Syfovre (pegcetacoplan) and Izervay (avacincaptad pegol). Both medications work by controlling inflammation and can help slow the progression of the disease. Additionally, eye doctors recommend taking AREDS2 supplements, which contain specific amounts of vitamins C and E, copper, zinc, lutein, and zeaxanthin. These supplements have been proven in clinical trials to help slow the progression of dry AMD. However, they are only recommended for people who already have dry AMD, not as a preventive measure. Research continues to advance, with ongoing clinical trials studying new potential treatments including photobiomodulation (light therapy), new medications, and cell transplantation treatments. You may want to discuss these new treatment options with your eye doctor to see if they might be appropriate for your specific situation.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Blindness or Vision Loss From Dry Age-Related Macular Degeneration: How Long It Takes

Wet AMD vs. Dry AMD: 4 Differences and 3 Similarities